Skip to main content

Table 3 Differences in clinical outcomes between Intervention group and Control Group (1)

From: Assessing the efficacy of a modified assertive community-based treatment programme in a developing country

Item

Intervention

Control

   
  

Mean (±SD)

n

Mean (±SD)

n

t-value

df

p

Baseline (mean)

PANNS-P total

32.29 (±5.62)

31

31.43 (±5.21)

21

0.56

50

0.58

 

PANNS-N total

25.06 (±6.82)

31

20.00 (±6.80)

21

2.63

50

0.01*

 

PANNS-G total

48.16 (±9.21)

31

45.67 (±6.37)

21

1.08

50

0.29

Intervention (n = 31)

Control (n = 21)

PANNS-Total

105.52 (±18.58)

31

97.10 (±15.20)

21

1.72

50

0.09

 

SOFAS

34.29 (±3.58)

31

36.29 (±6.37)

21

-0.89

50

0.38

 

CDSS

2.35 (±18.58)

31

1.05 (±1.47)

21

1.58

50

0.12

 

ESRS-questionnaire

3.16 (±2.48)

31

2.43 (±2.40)

21

1.06

50

0.29

 

ESRS-parkinsonism

8.84 (±7.28)

31

8.81 (±5.55)

21

0.02

50

0.99

 

ESRS-dystonia

0.00 (±0.00)

31

0.10 (±0.44)

21

-1.22

50

0.23

 

ESRS-dyskinetic

0.61 (±2.38)

31

0.57 (±2.62)

21

0.06

50

0.95

Endpoint

PANNS-P total

12.52 (±6.0)

29

19.38 (±8.8)

21

-3.28

48

0.00*

 

PANNS-N total

16.55 (±6.1)

29

19.33 (±4.6)

21

-1.76

48

0.09

 

PANNS-G total

28.45 (±8.2)

29

34.81 (±9.1)

21

-2.58

48

0.01*

 

PANNS-Total

57.52 (±17.4)

29

73.52 (±19.2)

21

-3.07

48

0.00*

Intervention ( n = 29)

Control (n = 21)

SOFAS

61.97 (±9.1)

29

54.90 (±10.8)

21

2.50

48

0.02*

 

CDSS total

0.69 (±1.4)

29

0.81 (±3.3)

21

 

48

0.86

 

ESRS-questionnaire

1.90 (±1.23)

29

1.90 (±1.51)

21

-0.02

48

0.98

 

ESRS-parkinsonism

9.03 (±8.20)

29

0.48 (±8.07)

21

0.48

48

0.63

 

ESRS-dystonia

0.00 (±0.00)

29

0.00 (±0.00)

21

 

48

 
 

ESRS-dyskinetic

0.55 (±1.24)

29

0.57 (±1.57)

21

-0.05

48

0.96

  1. *Significance at p < 0.05